Nucleo Advisory
We know the evidence. We know the channel.
The commercial arm of Nucleo: advisory and brokerage between manufacturers of evidence-based molecules and the distributors, agents and clinics that can place them. Paid, declared, and walled off from the observatory.
Why us
We read the literature daily
The observatory means we already know which molecules hold up and which are marketing. That judgement is what a distributor is actually buying.
We know the sales side
This is run by someone who sells in this sector — pharmacy, derma and specialist channels — not by a consultancy reading slides.
Fees agreed upfront
Advisory and introduction fees are agreed in writing before any work starts. No hidden margins, no pay-to-play.
Who we work with
Manufacturers & brands
You have a formulation with real human data and need distribution in a new market — or a channel that will understand the evidence instead of discounting it.
Distributors & retailers
You want a line that survives scrutiny, with the evidence documented before you commit shelf space or a sales force to it.
Agents & sales reps
You want products you can defend in front of a pharmacist or a clinician without overselling.
Clinics & practitioners
You want suppliers whose claims match the literature, sourced through someone who checks.
How it works
- 01Brief. You tell us the product, the market and what you need — placement, sourcing, a partner in a territory.
- 02Assessment. We look at the evidence behind the product and at whether the fit is real. If it isn't, we say so and stop.
- 03Scope & fee. We agree in writing what we do and what it costs, before any introduction happens.
- 04Introduction & follow-through. We make the introduction and stay in it until the parties are talking directly.
The wall — read this
Nucleo Advisory is a paid commercial service. Nucleo Longevity — the observatory, the A–F grades, the evidence — is not for sale, at any price.
Paying us never buys, raises, or softens a grade. It never removes a limitation, a risk, or a safety note from an entry.
No client sees a grade before publication or can request a change to one. If a molecule we are commercially involved with grades badly, it grades badly in public.
If we cannot do this cleanly for a given engagement, we decline the engagement rather than bend the editorial line.
Start a conversation
Tell us which side you're on and what you need. No obligation, no fee to talk.
Looking for the free directory instead? That's Nucleo Connect.
Nucleo Advisory does not sell, distribute or hold stock of any product, and gives no medical advice. Engagements are commercial services between businesses. AGREEMENT REQUIRED before any engagement begins.